SCHEMBL5428018

SCHEMBL5428018

CC[C@@H]1C(=O)NN=C(c2ccccc2O)c2cc(OC)c(OC)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
PDE4A P27815 2/20 0.41
PDE4D Q08499 2/20 0.41
PDE3A Q14432 2/20 0.41
CHRM1 P11229 1/20 0.41
HSP90AA1 P07900 2/20 0.39
HSP90AB1 P08238 2/20 0.39
MAPK1 P28482 5/20 0.38
TSHR P16473 4/20 0.38
LMNA P02545 4/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPT P10636 7/20 0.38
ALOX15 P16050 4/20 0.38
USP2 O75604 2/20 0.38
GPR55 Q9Y2T6 2/20 0.38
GAA P10253 3/20 0.37
ERBB2 P04626 1/20 0.37
POLB P06746 3/20 0.37
TP53 P04637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5426505 1.00 MEN1 (0.41) MEN1KMT2APDE4APDE4DPDE3A
SCHEMBL7408243 0.91 KDM4E (0.37) MEN1KMT2ATSHRLMNANPSR1
SCHEMBL5424906 0.90 PDE4A (0.44) MEN1KMT2APDE4APDE4DPDE3A
SCHEMBL5439697 0.90 PDE4A (0.44) MEN1KMT2APDE4APDE4DPDE3A
SCHEMBL5430941 0.80 PDE4A (0.61) MEN1KMT2APDE4APDE4DPDE3A
SCHEMBL5428060 0.80 PDE4A (0.61) MEN1KMT2APDE4APDE4DPDE3A
SCHEMBL5437849 0.79 PDE4A (0.51) MEN1KMT2APDE4APDE4DPDE3A
SCHEMBL5431218 0.79 PDE4A (0.51) MEN1KMT2APDE4APDE4DPDE3A
SCHEMBL5436368 0.76 PDE4A (0.56) MEN1KMT2APDE4APDE4DPDE3A
SCHEMBL5431284 0.76 PDE4A (0.56) MEN1KMT2APDE4APDE4DPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070161628-A1 Phosphodiesterase inhibitors GREENPHARMA (FR) 2007-07-12 US claimed
US-20070161628-A1 Phosphodiesterase inhibitors GREENPHARMA (FR) 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161628-A1 Phosphodiesterase inhibitors PDE5A, PDE3A, PDE3B MEN1 3432/4885KMT2A 2209/4885PDE4A 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.